← Open Payments lookup

LEAH ROGERS: Open Payments

NPI 1982965224 · WARSAW, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$352 in 20 payments from 11 companies in 2025. Trend: 2023 $271 · 2024 $439 · 2025 $352

Food & beverage: $352
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$75
Otsuka America Pharmaceutical, Inc.4$63
Merck Sharp & Dohme LLC3$53
ABBVIE INC.2$34
Astellas Pharma US Inc1$25
Dexcom, Inc.1$24
Novartis Pharmaceuticals Corporation1$19
Boehringer Ingelheim Pharmaceuticals, Inc.1$16
AstraZeneca Pharmaceuticals LP1$16
Exact Sciences Corporation1$15

Products named: CAPLYTA, REXULTI, VRAYLAR, Veozah, Dexcom G6 Transmitter, LEQVIO, M-M-R II, ENFLONSIA.

Industry payments across MO — which companies pay providers there.